These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 21243785)
21. Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary Syndrome. Lejealle C; Paradis V; Bruno O; de Raucourt E; Francoz C; Soubrane O; Lebrec D; Bedossa P; Valla D; Mal H; Vilgrain V; Durand F; Rautou PE Chest; 2019 Jan; 155(1):123-136. PubMed ID: 30292761 [TBL] [Abstract][Full Text] [Related]
22. Screening of hepatopulmonary syndrome (HPS) with CEUS and pulse-oximetry in liver cirrhosis patients eligible for liver transplant. Suceveanu AI; Mazilu L; Tomescu D; Ciufu N; Parepa IR; Suceveanu AP Chirurgia (Bucur); 2013; 108(5):684-8. PubMed ID: 24157113 [TBL] [Abstract][Full Text] [Related]
23. Cirrhosis and hepatopulmonary syndrome. Tumgor G World J Gastroenterol; 2014 Mar; 20(10):2586-94. PubMed ID: 24627594 [TBL] [Abstract][Full Text] [Related]
24. Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension. Møller S; Krag A; Madsen JL; Henriksen JH; Bendtsen F Liver Int; 2009 Nov; 29(10):1528-37. PubMed ID: 19725890 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary vascular abnormalities in cirrhosis. Herve P; Le Pavec J; Sztrymf B; Decante B; Savale L; Sitbon O Best Pract Res Clin Gastroenterol; 2007; 21(1):141-59. PubMed ID: 17223502 [TBL] [Abstract][Full Text] [Related]
26. Isolated Intrapulmonary Vascular Dilatations and the Risk of Developing Hepatopulmonary Syndrome in Liver Transplant Candidates. Mendizabal M; Goldberg DS; Piñero F; Arufe DT; José de la Fuente M; Testa P; Coronel M; Baratta S; Podestá LG; Fallon MB; Silva MO Ann Hepatol; 2017; 16(4):548-554. PubMed ID: 28611257 [TBL] [Abstract][Full Text] [Related]
30. [Gaseous disorders and their role in the development of hepatopulmonary syndrome in liver cirrhosis associated with COPD]. Nevzorova VA; Pestrikova TL; Kochetkova EA; Mokshina MV; Osvald M; Dutrele S; Massard Zh Eksp Klin Gastroenterol; 2013; (6):11-4. PubMed ID: 24772853 [TBL] [Abstract][Full Text] [Related]
31. Screening for Hepatopulmonary Syndrome in Cirrhotic Patients Using Technetium 99m-macroaggregated Albumin Perfusion Lung Scan (Tc-MAA): Diagnostic Approach and Clinical Correlations. Fragaki M; Sifaki-Pistolla D; Samonakis DN; Koulentaki M; Koukouraki S; Stathaki M; Kouroumalis E J Clin Gastroenterol; 2018 Oct; 52(9):828-834. PubMed ID: 28961571 [TBL] [Abstract][Full Text] [Related]
32. The utility of the macro-aggregated albumin lung perfusion scan in the diagnosis and prognosis of hepatopulmonary syndrome in cirrhotic patients candidates for liver transplantation. Grilo I; Pascasio JM; Tirado JL; López-Pardo FJ; Ortega-Ruiz F; Sousa JM; Rodríguez-Puras MJ; Ferrer MT; Gómez-Bravo MÁ; Grilo Reina A Rev Esp Enferm Dig; 2017 May; 109(5):335-343. PubMed ID: 28301945 [TBL] [Abstract][Full Text] [Related]
34. Prevalence and characteristics of hepatopulmonary syndrome in children with cirrhosis in southern Brazil. Ceza MR; Garcia E; Anselmi CE; Epifanio M; Melere MU; Ferreira CT; Steinhaus C; Coral GP Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):10-15. PubMed ID: 30045096 [TBL] [Abstract][Full Text] [Related]
35. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis. Horvatits T; Drolz A; Roedl K; Herkner H; Ferlitsch A; Perkmann T; Müller C; Trauner M; Schenk P; Fuhrmann V J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623 [TBL] [Abstract][Full Text] [Related]